CGP 20712 (dihydrochloride)
CGP 20712 dihydrochloride is a highly selective β1-adrenoceptor antagonist with an IC50 of 0.7 nM. CGP 20712 dihydrochloride exhibits ~10,000-fold selectivity over β2-adrenoceptors[1].
Product Specifications
CAS Number
1216905-73-5
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Adrenergic Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Endocrinology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/cgp-20712-dihydrochloride.html
Purity
99.4
Solubility
DMSO : 28 mg/mL (ultrasonic; warming)
Smiles
O=C(N)C1=CC(OCCNCC(O)COC2=CC=C(C3=NC(C(F)(F)F)=CN3C)C=C2)=CC=C1O.Cl.Cl
Molecular Formula
C23H27Cl2F3N4O5
Molecular Weight
567.39
Precautions
H302, H315, H319, H335
References & Citations
[1]Kitagawa Y, et al. Determination of beta-adrenoceptor subtype on rat isolated ventricular myocytes by use of highly selective beta-antagonists. Br J Pharmacol. 1995 Sep;116 (1) :1635-43.|[2]Dooley DJ, et al. CGP 20712 A: a useful tool for quantitating beta 1- and beta 2-adrenoceptors. Eur J Pharmacol. 1986 Oct 14;130 (1-2) :137-9.|[3]Kitagawa Y, et al. Determination of beta-adrenoceptor subtype on rat isolated ventricular myocytes by use of highly selective beta-antagonists. Br J Pharmacol. 1995 Sep;116 (1) :1635-43.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC941687-500 1x 500 µL
VEGF (Vascular Endothelial Growth Factor) (VG76e), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC742876-500 1x 500 µL
CD31 / PECAM-1 (Endothelial Cell Marker) (C31/2876R), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 